Albany International Corp. — Q1 2023 Form 10-Q Summary
Business context and reporting period
Albany International Corp. reported results for the three months ended March 31, 2023. The company operates through two segments: Machine Clothing (MC), which serves paper, packaging, tissue, nonwovens, and industrial markets, and Albany Engineered Composites (AEC), which serves commercial and defense aerospace programs.
Financial performance and position
- Net sales: $269.1 million, up 10.2% year over year; excluding currency translation effects, sales increased 12.2%.
- Gross profit: $99.3 million, with a 36.9% gross margin versus 37.5% in the prior-year quarter.
- Operating income: $40.5 million, up from $38.8 million; operating margin was approximately 15.1% versus 15.9%.
- Net income attributable to the Company: $26.9 million, compared with $27.7 million; diluted EPS was $0.86 versus $0.87.
- Adjusted EPS: $0.91 in both periods, as reported by management using non-GAAP adjustments.
- Adjusted EBITDA: $60.4 million versus $61.0 million; adjusted EBITDA margin was approximately 22.4% versus 25.0%.
- Cash flow: Operating activities used $16.4 million versus $5.4 million used in the prior-year quarter. Capital expenditures were $16.3 million versus $15.8 million.
- Liquidity: Cash and cash equivalents were $304.3 million at March 31, 2023. Management reported approximately $209 million of additional borrowing availability, or total liquidity of approximately $513 million.
- Debt: Long-term debt was $491.0 million, up from $439.0 million at December 31, 2022. Net debt was $186.7 million, and the reported net leverage ratio was 0.74x.
- Dividends: The quarterly dividend declared was $0.25 per share, versus $0.21 in the prior-year quarter. The company paid $7.8 million in dividends during the quarter.
Material changes versus the prior comparable period
- AEC growth: AEC sales increased 28.6% to $115.9 million, driven primarily by CH-53K and LEAP programs. AEC operating income rose to $9.4 million from $1.2 million, and gross margin improved to 18.5% from 13.6%.
- MC stability with margin pressure: MC sales declined 0.5% as reported but increased 1.7% excluding currency effects. Operating income declined to $49.0 million from $49.6 million, while gross margin fell to 50.8% from 51.5% because of higher input costs.
- Currency impact: Currency translation reduced consolidated sales by approximately $5.0 million. Other income and expense shifted from $3.9 million of income to $0.5 million of income, primarily because foreign currency gains in the prior year became a small loss.
- Working capital investment: Accounts receivable, contract assets, and inventories increased during the quarter, reflecting AEC production and demand-related investment. This contributed to the decline in operating cash flow.
- Financing activity: The company borrowed $58.0 million and repaid $6.0 million of debt. It made no share repurchases, compared with $42.2 million of treasury-share purchases in the prior-year quarter.
Guidance, outlook, risks, and unusual items
- The filing does not provide a clear quantitative full-year earnings or revenue guidance figure.
- Management views MC as a stable cash-generating business but cites declining publication-paper demand, pricing pressure, and inflation in labor, raw materials, energy, and logistics.
- Management identifies AEC as a longer-term growth platform, supported by LEAP, CH-53K, F-35, JASSM, Boeing 787, and other aerospace programs. Remaining performance obligations on contracts with original durations exceeding one year totaled $821 million at March 31, 2023, with approximately $126 million expected to be recognized during 2023.
- AEC contract profitability depends on estimates under cost-to-cost accounting. Changes in estimated contract profitability reduced operating income by $0.7 million in the quarter, consistent with the prior year.
- Reported results included minimal restructuring expense, $1.9 million of foreign-currency revaluation losses, and $0.3 million of acquisition/integration costs. The prior-year period included a $2.6 million charge related to dissolution of business relationships in Russia and a $2.3 million foreign-currency revaluation gain.
- The company was in compliance with debt covenants. The revolving credit facility and certain derivatives reference USD LIBOR, which was scheduled to discontinue after June 30, 2023; management did not expect the transition to materially affect results, financial position, or cash flows.
- Albany was defending 3,597 asbestos claims at March 31, 2023. Management stated that available insurance and defenses make a material adverse outcome unlikely, but the company cannot estimate a range of reasonably possible loss beyond accrued amounts.
Important facts for investors to verify
- Whether AEC production growth and program execution, particularly on LEAP and CH-53K, support sustained margin improvement.
- Whether MC pricing, productivity initiatives, and demand in packaging and tissue offset inflation and declining publication-paper demand.
- The conversion of AEC contract assets and inventories into billed revenue and operating cash flow.
- The maturity and refinancing plan for the $491.0 million revolving-credit balance due in 2024, including the effect of benchmark-rate transition.
- Future changes in aerospace customer demand, supply-chain conditions, contract estimates, and potential losses on new programs.
- Developments in asbestos litigation, insurance coverage, and any changes to the company’s assessment of potential exposure.